Top Tweets for #AllostericModulators
Our CEO, Tim Dyer, will be attending the 24th Annual Biotech in Europe Forum, #Sachs_BEF (25 – 26 September) in Basel. If you’re interested in hearing about @AddexPharma - Addex Therapeutics and our pipeline of #allostericmodulators for #neurologicaldisorders,
Thanks David Wild @davidwild77 and In Vivo, Citeline Commercial @INVIVOnow for covering Addex and outlining our journey for the past 22 years advancing the field of #allostericmodulators. Despite the ups and downs of #drugdevelopment,
Here at Addex, we will continue to invest in #drugresearch focusing on the benefits of #allostericmodulators until one day soon, we hope there will be a cure #Parkinsonsawareness #dipraglurant #allostericmodulators #PD-LID #thespark
and webcast at 16:00 CET (15:00 GMT / 10:00 EST / 07:00 PST). #allostericmodulators #financialresults
https://t.co/JMDDxPbI04
With @PerceptiveAdvi2 Perceptive Advisors, we are excited to launch Neurosterix to develop #allostericmodulators for #neurologicaldisorders. With technology and preclinical assets from Addex, Neurosterix will use its $63M #SeriesA to accelerate development towards the clinic
Our CEO, Tim Dyer, speaks to @proactive_UK @proactive_NA Proactive Investors about our expertise in developing #allostericmodulators for #CNS disorders as well as progress being made across our portfolio,
Data from a landmark study published in Brain demonstrates the potential therapeutic role of #mGlu5 receptor negative #allostericmodulators (NAMs) in facilitating functional recovery following #stroke. At Addex, we believe this supports the future development of #dipraglurant in
Excited to announce data in Neuropharmacology showing our mGlu2 positive #allostericmodulators (#PAMS) could treat #opioid use disorder. With The @scrippsresearch Institute, we showed mGlu2 PAMs can decrease #glutamate activity and stop oxycodone self-administration.
- advances in G protein coupled receptor (#GPCR) research. Get in touch if you’re interested in catching up with Dominik to discuss how Addex is using its expertise in targeting GPCRs with #allostericmodulators in #drugdiscovery & #drugdevelopment ([email protected]).
Great to see this @MonashUni study published in @eLife. It brings insight into the specific binding pocket for positive #allostericmodulators (PAMs) of the #muscarinic M4 receptor and continues broadening our overall understanding of allosteric binding pockets. This is important
at 16:00 CEST (15:00 BST / 10:00 EDT / 07:00 PDT) later today for a business update and a review of the Addex product pipeline during a teleconference and webcast. #allostericmodulators #financialresults #drugdevelopment
https://t.co/vcRHDjbk2b
Please contact us via the conference partnering system or [email protected]. #allostericmodulators #CNS #drugdiscovery #drugdevelopment
https://t.co/Tinl1GXcwc
and a review of the Addex product pipeline during a teleconference and webcast. #allostericmodulators #financialresults #DrugDevelopment
https://t.co/IpfdRvhTTc
Tim will be available to connect for a 1-to-1 meeting via the online partnering platform or reach out on [email protected]. #allostericmodulators #Swissbiotech #biotech
we continue to invest in #drugresearch focusing on the benefits of #allostericmodulators so that together we can put Parkinson’s in the past.
#thespark @ParkinsonsSpark
Interested in knowing more about #allostericmodulators in #drugdiscovery and #drugdevelopment? Join us at one of these conferences:
•Bio-Europe Spring: March 20 – 23, 2023; Basel, Switzerland.
•Swiss Biotech Day: April 24 – 25, 2023; Basel, Switzerland.
Today, in our corporate update, we have provided our current cash position and outlined the status of our ongoing activities, including clinical and preclinical product development. #allostericmodulators #drugdevelopment
https://t.co/oMBCv2QEmI
Very pleased to announce that we have extended our existing collaboration agreement with @Indivior for discovering and developing novel #GABAB positive #allostericmodulators in #substanceuse disorders. Addex will receive additional research funding from Indivior and continue
Tim Dyer, Chief Executive Officer, Mikhail Kalinichev, Head of Translational Science and @rlutjens Robert Lütjens, Head of Discovery Biology will deliver a brief presentation followed by a Q&A session. #allostericmodulators #financialresults #CNS #drugdevelopment
Last Seen Hashtags on Sotwe
nolimit
nolimit() +filter:native_video
Seen from United Kingdom
nolimit filter:videos
Seen from Thailand
妈妈
Seen from Egypt
Porn
Seen from United Kingdom
TheBoltsDay
Seen from United States
meenakshisudheer
Seen from United Arab Emirates
teeNager filter:native_video
Seen from United States
フィギュアぶっかけ
Seen from Japan
bbc marocaine
Most Popular Users
Elon Musk 
@elonmusk
240.6M followers
Barack Obama
@barackobama
119.3M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
110.4M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.6M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
90.9M followers
KATY PERRY
@katyperry
87.6M followers
Taylor Swift
@taylorswift13
81.4M followers
Lady Gaga
@ladygaga
72.9M followers
Virat Kohli
@imvkohli
69.7M followers
Kim Kardashian
@kimkardashian
69.7M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
63.8M followers
Neymar Jr
@neymarjr
62.5M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
X
@x
60.8M followers
Selena Gomez
@selenagomez
60.7M followers